Active topical NS2 1% dermatologic cream — Competitive Intelligence Brief

Active topical NS2 1% dermatologic cream (Active topical NS2 1% dermatologic cream) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical anti-inflammatory. Area: Dermatology.

phase 2 Topical anti-inflammatory Dermatology Small molecule

Target snapshot

Active topical NS2 1% dermatologic cream (Active topical NS2 1% dermatologic cream) — Aldeyra Therapeutics, Inc.. Active topical NS2 1% dermatologic cream works by targeting the underlying cause of inflammation in the skin.

Comparator set (3 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Active topical NS2 1% dermatologic cream TARGET	Active topical NS2 1% dermatologic cream	Aldeyra Therapeutics, Inc.	phase 2	Topical anti-inflammatory
PAL	PAL	Folia Biotech Inc.	marketed	Topical anti-inflammatory/analgesic	PPAR-α; endocannabinoid system
KPI-121 Ophthalmic Suspension	KPI-121 Ophthalmic Suspension	Kala Pharmaceuticals, Inc.	phase 3	TRPV1 antagonist / Topical anti-inflammatory	TRPV1 (Transient Receptor Potential Vanilloid 1)
Total coumarin (TC) cream	Total coumarin (TC) cream	Psoriasis Research Institute of Guangzhou	phase 3	Herbal/botanical topical anti-inflammatory

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical anti-inflammatory class)

1. Aldeyra Therapeutics, Inc. · 1 drug in this class
2. BRIM Biotechnology Inc. · 1 drug in this class
3. BioCis Pharma Ltd · 1 drug in this class